AAAAAA

   
Results: 1-17 |
Results: 17
A PHASE-I AND PHARMACOKINETIC STUDY OF LY231514, THE MULTITARGETED ANTIFOLATE
Authors: MCDONALD AC VASEY PA ADAMS L WALLING J WOODWORTH JR ABRAHAMS T MCCARTHY S BAILEY NP SIDDIQUI N LIND MJ CALVERT AH TWELVES CJ CASSIDY J KAYE SB
Citation: Ac. Mcdonald et al., A PHASE-I AND PHARMACOKINETIC STUDY OF LY231514, THE MULTITARGETED ANTIFOLATE, Clinical cancer research, 4(3), 1998, pp. 605-610
A PHASE-I AND PHARMACOKINETIC STUDY OF LY231514, THE MULTITARGETED ANTIFOLATE
Authors: MCDONALD AC VASEY PA ADAMS L WALLING J WOODWORTH JR ABRAHAMS T MCCARTHY S BAILEY NP SIDDIQUI N LIND MJ CALVERT AH TWELVES CJ CASSIDY J KAYE SB
Citation: Ac. Mcdonald et al., A PHASE-I AND PHARMACOKINETIC STUDY OF LY231514, THE MULTITARGETED ANTIFOLATE, Clinical cancer research, 4(3), 1998, pp. 605-610
PRECLINICAL AND PHASE-I CLINICAL-STUDIES WITH THE NONCLASSICAL ANTIFOLATE THYMIDYLATE SYNTHASE INHIBITOR NOLATREXED DIHYDROCHLORIDE GIVEN BY PROLONGED ADMINISTRATION IN PATIENTS WITH SOLID TUMORS
Authors: RAFI I BODDY AV CALVETE JA TAYLOR GA NEWELL DR BAILEY NP LIND MJ GREEN M HINES J JOHNSTONE A CLENDENINN N CALVERT AH
Citation: I. Rafi et al., PRECLINICAL AND PHASE-I CLINICAL-STUDIES WITH THE NONCLASSICAL ANTIFOLATE THYMIDYLATE SYNTHASE INHIBITOR NOLATREXED DIHYDROCHLORIDE GIVEN BY PROLONGED ADMINISTRATION IN PATIENTS WITH SOLID TUMORS, Journal of clinical oncology, 16(3), 1998, pp. 1131-1141
O-6-METHYLGUANINE-DNA METHYLTRANSFERASE IN PRETREATMENT TUMOR-BIOPSIES AS A PREDICTOR OF RESPONSE TO TEMOZOLOMIDE IN MELANOMA
Authors: MIDDLETON MR LUNN JM MORRIS C RUSTIN G WEDGE SR BRAMPTON MH LIND MJ LEE SM NEWELL DR BLEEHEN NM NEWLANDS ES CALVERT AH MARGISON GP THATCHER N
Citation: Mr. Middleton et al., O-6-METHYLGUANINE-DNA METHYLTRANSFERASE IN PRETREATMENT TUMOR-BIOPSIES AS A PREDICTOR OF RESPONSE TO TEMOZOLOMIDE IN MELANOMA, British Journal of Cancer, 78(9), 1998, pp. 1199-1202
A CLINICAL AND PHARMACOKINETIC STUDY OF THE COMBINATION OF CARBOPLATIN AND PACLITAXEL FOR EPITHELIAL OVARIAN-CANCER
Authors: SIDDIQUI N BODDY AV THOMAS HD BAILEY NP ROBSON L LIND MJ CALVERT AH
Citation: N. Siddiqui et al., A CLINICAL AND PHARMACOKINETIC STUDY OF THE COMBINATION OF CARBOPLATIN AND PACLITAXEL FOR EPITHELIAL OVARIAN-CANCER, British Journal of Cancer, 75(2), 1997, pp. 287-294
PHASE-I STUDY OF PHARMACOLOGICALLY BASED DOSING OF CARBOPLATIN WITH FILGRASTIM SUPPORT IN WOMEN WITH EPITHELIAL OVARIAN-CANCER
Authors: LIND MJ GHAZALASWAD S GUMBRELL L FISHWICK K CRAIGS D MILLWARD MJ BAILEY NP DOREGREEN F CHAPMAN F SIMMONS D PROCTOR M OAKEY A ROBSON L MIDDLETON I MCCANN E SINHA D CALVERT AH
Citation: Mj. Lind et al., PHASE-I STUDY OF PHARMACOLOGICALLY BASED DOSING OF CARBOPLATIN WITH FILGRASTIM SUPPORT IN WOMEN WITH EPITHELIAL OVARIAN-CANCER, Journal of clinical oncology, 14(3), 1996, pp. 800-805
THE ROLE OF IFOSFAMIDE IN THE TREATMENT OF BREAST-CANCER AND SARCOMA
Authors: LIND MJ
Citation: Mj. Lind, THE ROLE OF IFOSFAMIDE IN THE TREATMENT OF BREAST-CANCER AND SARCOMA, Eksperimental'naa onkologia, 18(1), 1996, pp. 66-68
A PHASE-I CLINICAL-STUDY OF THE ANTIPURINE ANTIFOLATE LOMETREXOL (DDATHF) GIVEN WITH ORAL FOLIC-ACID
Authors: LAOHAVINIJ S WEDGE SR LIND MJ BAILEY N HUMPHREY A PROCTOR M CHAPMAN F SIMMONS D OAKLEY A ROBSON L GUMBRELL L TAYLOR GA THOMAS HD BODDY AV NEWELL DR CALVERT AH
Citation: S. Laohavinij et al., A PHASE-I CLINICAL-STUDY OF THE ANTIPURINE ANTIFOLATE LOMETREXOL (DDATHF) GIVEN WITH ORAL FOLIC-ACID, Investigational new drugs, 14(3), 1996, pp. 325-335
PHASE-I AND PHARMACOKINETIC STUDY OF A WATER-SOLUBLE ETOPOSIDE PRODRUG, ETOPOSIDE PHOSPHATE (BMY-40481)
Authors: MILLWARD MJ NEWELL DR MUMMANENI V IGWEMEZIE LN BALMANNO K CHARLTON CJ GUMBRELL L LIND MJ CHAPMAN F PROCTOR M SIMMONDS D CANTWELL BMJ TAYLOR GA MCDANIEL C WINOGRAD B KAUL S BARBAIYA RH CALVERT AH
Citation: Mj. Millward et al., PHASE-I AND PHARMACOKINETIC STUDY OF A WATER-SOLUBLE ETOPOSIDE PRODRUG, ETOPOSIDE PHOSPHATE (BMY-40481), European journal of cancer, 31A(13-14), 1995, pp. 2409-2411
PHARMACOKINETICS, METABOLISM AND CLINICAL EFFECT OF IFOSFAMIDE IN BREAST-CANCER PATIENTS
Authors: BODDY AV PROCTOR M SIMMONDS D LIND MJ IDLE JR
Citation: Av. Boddy et al., PHARMACOKINETICS, METABOLISM AND CLINICAL EFFECT OF IFOSFAMIDE IN BREAST-CANCER PATIENTS, European journal of cancer, 31A(1), 1995, pp. 69-76
PHARMACOKINETICS AND PHARMACODYNAMICS OF PROLONGED ORAL ETOPOSIDE IN WOMEN WITH METASTATIC BREAST-CANCER
Authors: MILLWARD MJ NEWELL DR YUEN K MATTHEWS JP BALMANNO K CHARLTON CJ GUMBRELL L LIND MJ CHAPMAN F PROCTOR M SIMMONDS D CANTWELL BMJ CALVERT AH
Citation: Mj. Millward et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF PROLONGED ORAL ETOPOSIDE IN WOMEN WITH METASTATIC BREAST-CANCER, Cancer chemotherapy and pharmacology, 37(1-2), 1995, pp. 161-167
CARBOPLATIN IN COMBINATION WITH PACLITAXEL IN ADVANCED OVARIAN-CANCER- DOSE DETERMINATION AND PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS
Authors: CALVERT AH BODDY A BAILEY NP SIDDIQUI N HUMPHREYS A HUGHES A ROBSON L GUMBRELL L THOMAS H CHAPMAN F PROCTOR M SIMMONS D OAKEY A LIND MJ SINHA DV NEWELL DR
Citation: Ah. Calvert et al., CARBOPLATIN IN COMBINATION WITH PACLITAXEL IN ADVANCED OVARIAN-CANCER- DOSE DETERMINATION AND PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS, Seminars in oncology, 22(5), 1995, pp. 91-98
THE USE OF GRANULOCYTE-COLONY-STIMULATING FACTOR TO DELIVER 4 CYCLES OF IFOSFAMIDE AND EPIRUBICIN EVERY 14 DAYS IN WOMEN WITH ADVANCED OR METASTATIC BREAST-CANCER
Authors: LIND MJ GUMBRELL L CANTWELL BMJ MILLWARD MJ SIMMONDS D PROCTOR M CHAPMAN F MCCANN E MIDDLETON I CALVERT AH
Citation: Mj. Lind et al., THE USE OF GRANULOCYTE-COLONY-STIMULATING FACTOR TO DELIVER 4 CYCLES OF IFOSFAMIDE AND EPIRUBICIN EVERY 14 DAYS IN WOMEN WITH ADVANCED OR METASTATIC BREAST-CANCER, British Journal of Cancer, 71(3), 1995, pp. 610-613
CARBOPLATIN AND GRANULOCYTE-COLONY-STIMULATING FACTOR AS FIRST-LINE TREATMENT FOR EPITHELIAL OVARIAN-CANCER - A PHASE-I DOSE-INTENSITY ESCALATION STUDY
Authors: CALVERT AH LIND MJ GHAZALASWAD S GUMBRELL L MILLWARD MJ BAILEY NP DOREGREEN F CHAPMAN F SIMMONS D PROCTOR M OAKEY A SINHA DP MCCANN E MIDDLETON I
Citation: Ah. Calvert et al., CARBOPLATIN AND GRANULOCYTE-COLONY-STIMULATING FACTOR AS FIRST-LINE TREATMENT FOR EPITHELIAL OVARIAN-CANCER - A PHASE-I DOSE-INTENSITY ESCALATION STUDY, Seminars in oncology, 21(5), 1994, pp. 1-6
IDENTIFICATION OF THE MAJOR HUMAN HEPATIC CYTOCHROME-P450 INVOLVED INACTIVATION AND N-DECHLOROETHYLATION OF IFOSFAMIDE
Authors: WALKER D FLINOIS JP MONKMAN SC BELOC C BODDY AV CHOLERTON S DALY AK LIND MJ PEARSON ADJ BEAUNE PH IDLE JR
Citation: D. Walker et al., IDENTIFICATION OF THE MAJOR HUMAN HEPATIC CYTOCHROME-P450 INVOLVED INACTIVATION AND N-DECHLOROETHYLATION OF IFOSFAMIDE, Biochemical pharmacology, 47(7), 1994, pp. 1157-1163
LONG-TERM ORAL ETOPOSIDE IN METASTATIC BREAST-CANCER - CLINICAL AND PHARMACOKINETIC RESULTS
Authors: CALVERT AH LIND MJ MILLWARD MM CANTWELL BMJ GUMBRELL L PROCTOR M SIMMONS D CHAPMAN F ROBINSON A CHARLTON C BALMANNO K NEWELL D
Citation: Ah. Calvert et al., LONG-TERM ORAL ETOPOSIDE IN METASTATIC BREAST-CANCER - CLINICAL AND PHARMACOKINETIC RESULTS, Cancer treatment reviews, 19, 1993, pp. 27-33
PHARMACOKINETICS OF ALKYLATING-AGENTS
Authors: LIND MJ ARDIET C
Citation: Mj. Lind et C. Ardiet, PHARMACOKINETICS OF ALKYLATING-AGENTS, Cancer surveys, 17, 1993, pp. 157-188
Risultati: 1-17 |